—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Jazz Pharmaceuticals PLC (JAZZ) — Technical state

As of 2026-11-04 — re-computed nightly across the coverage universe. Closelooknet diary readings, not advice.

The Closelooknet read

  • Signal: Uptrend stack intact — Trades +2% vs the 50-day and +7.9% vs the 200-day average, 11.9% below the 52-week high and +82.2% off the 52-week low. Computed from daily closes. (as of 2026-11-04)
  • Trend: Jazz Pharmaceuticals PLC trades 2.0% above its 50-day and 7.9% above its 200-day moving average. (as of 2026-11-04)

Jazz Pharmaceuticals identifies, develops and sells prescription medicines, with a portfolio spanning sleep disorders, epilepsy, oncology and haematology. Its marketed products include treatments for narcolepsy, seizure disorders such as Lennox-Gastaut and Dravet syndromes, acute lymphoblastic leukaemia, and several solid-tumour cancers, alongside a pipeline of earlier-stage cancer and neurology candidates.

The full read — the desk's view, the earnings record, peers and the company snapshot — is on the JAZZ overview. Research diary readings, not advice.

Uptrend stack intact

Trades +2% vs the 50-day and +7.9% vs the 200-day average, 11.9% below the 52-week high and +82.2% off the 52-week low. Computed from daily closes.

The moving-average stack

Continue: the JAZZ chart & overview · the signal board

FAQ · from the current data · as of 2026-11-04

Quick answers

What is the current Closelooknet signal on JAZZ?

Uptrend stack intact — Trades +2% vs the 50-day and +7.9% vs the 200-day average, 11.9% below the 52-week high and +82.2% off the 52-week low. Computed from daily closes. As of 2026-11-04; the signal board re-computes across the coverage universe nightly. A research diary reading, not advice.

Is JAZZ above its 50-day and 200-day moving averages?

As of 2026-11-04, Jazz Pharmaceuticals PLC trades +2% above its 50-day and +7.9% above its 200-day average, with the 20-day +9.5% away.

How far is JAZZ from its 52-week high?

11.9% below the 52-week high and 82.2% above the 52-week low, as of 2026-11-04.

Related in the Closelooknet universe

then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.